J&J Pledges To Stop Animal Use In Sales Training
Executive Summary
The manufacturer was facing PETA protests in response to a leaked plan to allow pigs to die as part of sales-rep training later this month.
You may also be interested in...
Questions Surface In Response To FDA's Draft Guidance On Device Animal Studies
Industry and regulatory groups say FDA should make it clearer in a final guidance whether it intends to only address animal studies assessing safety or if it is also targeting performance studies in a draft guidance from October. There are also questions about reporting of raw data from animal studies, and PETA weighs in.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.